Literature DB >> 24701400

Acute kidney injury classification: AKIN and RIFLE criteria in critical patients.

Chan-Yu Lin1, Yung-Chang Chen1.   

Abstract

Acute kidney injury (AKI) is a common and serious complication in critically ill patients. The mortality rate remains high despite improved renal replacement techniques. A possible cause of the high mortality rate is that intensive care unit patients tend to be older and more debilitated than before. Pathophysiological factors associated with AKI are also implicated in the failure of other organs, indicating that AKI is often part of a multiple organ failure syndrome. Until recently, there was a lack of consensus as to the best definition, characterization, and evaluation of acute renal failure. This lack of a standard definition has been a major impediment to progress in clinical and basic research. The introduction of the risk, injury, failure, loss, and end-stage kidney disease criteria and the modified version proposed by the Acute Kidney Injury Network have increased the conceptual understanding of AKI syndrome, and these criteria have been successfully tested in clinical studies. This article reviews current findings concerning the application of these criteria for assessing epidemiology and predicting outcome in specific homogeneous critically ill patient groups.

Entities:  

Keywords:  Acute kidney injury; Acute respiratory distress syndrome; Cirrhosis; Extracorporeal membrane oxygenation; Intensive care unit; Sepsis

Year:  2012        PMID: 24701400      PMCID: PMC3953858          DOI: 10.5492/wjccm.v1.i2.40

Source DB:  PubMed          Journal:  World J Crit Care Med        ISSN: 2220-3141


  53 in total

1.  Acute kidney injury in the intensive care unit according to RIFLE.

Authors:  Marlies Ostermann; René W S Chang
Journal:  Crit Care Med       Date:  2007-08       Impact factor: 7.598

2.  Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability.

Authors:  A A Kramer; G Postler; K F Salhab; C Mendez; L C Carey; H Rabb
Journal:  Kidney Int       Date:  1999-06       Impact factor: 10.612

Review 3.  Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R LeGall; A Morris; R Spragg
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 4.  Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria.

Authors:  Zaccaria Ricci; Dinna N Cruz; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

5.  An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine.

Authors:  Laurent Brochard; Fekri Abroug; Matthew Brenner; Alain F Broccard; Robert L Danner; Miquel Ferrer; Franco Laghi; Sheldon Magder; Laurent Papazian; Paolo Pelosi; Kees H Polderman
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

Review 6.  Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.

Authors:  S G Coca; R Yalavarthy; J Concato; C R Parikh
Journal:  Kidney Int       Date:  2007-12-19       Impact factor: 10.612

Review 7.  Advances in critical care for the nephrologist: acute lung injury/ARDS.

Authors:  Kathleen D Liu; Michael A Matthay
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 8.237

8.  RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients.

Authors:  Chang-Chyi Jenq; Ming-Hung Tsai; Ya-Chung Tian; Chan-Yu Lin; Chun Yang; Nai-Jen Liu; Jau-Min Lien; Yung-Chang Chen; Ji-Tseng Fang; Pan-Chi Chen; Chih-Wei Yang
Journal:  Intensive Care Med       Date:  2007-06-30       Impact factor: 17.440

9.  Acute kidney injury biomarkers for patients in a coronary care unit: a prospective cohort study.

Authors:  Tien-Hsing Chen; Chih-Hsiang Chang; Chan-Yu Lin; Chang-Chyi Jenq; Ming-Yang Chang; Ya-Chung Tian; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang; Ming-Shien Wen; Fun-Chung Lin; Yung-Chang Chen
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  15 in total

1.  Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.

Authors:  Patrick S Kiley; Aaron P Pearston; Laura A Hodge; Marcus C Kaplan; Stephanie M Baczek; James S Stanley; Tyler J Wilson; Kristina M Soriano; Andrew Yao; Zachary A Shaeffer; Irene E Talt; Joshua A Cohen; Amanda I Ingemi
Journal:  Antimicrob Agents Chemother       Date:  2022-07-13       Impact factor: 5.938

Review 2.  Prevention and Management of AKI in ACS Patients Undergoing Invasive Treatments.

Authors:  Ravi A Thakker; Aiham Albaeni; Haider Alwash; Syed Gilani
Journal:  Curr Cardiol Rep       Date:  2022-08-04       Impact factor: 3.955

3.  Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.

Authors:  Abdullah F Al Harthi; Ohoud Aljuhani; Ghazwa B Korayem; Ali F Altebainawi; Raghdah S Alenezi; Shmeylan Al Harbi; Jawaher Gramish; Raed Kensara; Awattif Hafidh; Huda Al Enazi; Ahad Alawad; Rand Alotaibi; Abdulaziz Alshehri; Omar Alhuthaili; Ramesh Vishwakarma; Khalid Bin Saleh; Thamer Alsulaiman; Rahaf Ali Alqahtani; Sajid Hussain; Saja Almazrou; Khalid Al Sulaiman
Journal:  J Intensive Care Med       Date:  2022-04-21       Impact factor: 2.889

4.  Acute kidney injury following resection of hepatocellular carcinoma: prognostic value of the acute kidney injury network criteria

Authors:  Alexsander K. Bressan; Matthew T. James; Elijah Dixon; Oliver F. Bathe; Francis R. Sutherland; Chad G. Ball
Journal:  Can J Surg       Date:  2018-10-01       Impact factor: 2.089

5.  Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.

Authors:  Khalid Al Sulaiman; Ohoud Aljuhani; Maram Al Dossari; Asma Alshahrani; Aisha Alharbi; Rahmah Algarni; Majed Al Jeraisy; Shmeylan Al Harbi; Abdulmalik Al Katheri; Fahad Al Eidan; Abdulkareem M Al Bekairy; Nouf Al Qahtani; Mashael Al Muqrin; Ramesh Vishwakarma; Ghassan Al Ghamdi
Journal:  Crit Care       Date:  2021-06-30       Impact factor: 9.097

6.  Prognosis of critically ill cirrhotic versus non-cirrhotic patients: a comprehensive score-matched study.

Authors:  Chung-Ming Fu; Chih-Hsiang Chang; Pei-Chun Fan; Ming-Hung Tsai; Shu-Min Lin; Kuo-Chin Kao; Ya-Chung Tian; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang; Yung-Chang Chen
Journal:  BMC Anesthesiol       Date:  2014-12-17       Impact factor: 2.217

7.  Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.

Authors:  Ohoud Aljuhani; Khalid Al Sulaiman; Awatif Hafiz; Khalid Eljaaly; Aisha Alharbi; Rahmah Algarni; Sarah Al Homaid; Khawla Kahtani; Tareq Alsulaiman; Ramesh Vishwakarma; Ghassan Al Ghamdi; Mai Alalawi; Ghazwa B Korayem
Journal:  Saudi Pharm J       Date:  2022-02-03       Impact factor: 4.562

8.  Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.

Authors:  Khalid Al Sulaiman; Mashael Al Mutairi; Omar Al Harbi; Alanoud Al Duraihim; Sara Aldosary; Haifa Al Khalil; Abdulrahman Al Shaya; Shmeylan Al Harbi; Nouf Alotaibi; Kholoud Al Aamer; Ramesh Vishwakarma; Mohammed Al Asiri; Ohoud Aljuhani; Abdulmalik Al Katheri; Abdulkareem M Al Bekairy
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

9.  Melatonin in the prevention of cisplatin-induced acute nephrotoxicity: a randomized, controlled clinical trial.

Authors:  Sara Karvan; Alireza Sadeghi; Pegah Farrokhi; Amirabbass Nekouee; Mehran Sharifi; Azadeh Moghaddas
Journal:  Res Pharm Sci       Date:  2022-01-15

10.  Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial.

Authors:  Bram Rochwerg; Tina Millen; Peggy Austin; Michelle Zeller; Frédérick D'Aragon; Roman Jaeschke; Marie-Hélène Masse; Sangeeta Mehta; Francois Lamontagne; Maureen Meade; Gordon Guyatt; Deborah J Cook
Journal:  BMJ Open       Date:  2017-07-20       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.